Levi Strauss' (LEVI) most recent quarterly report showed that EBITDA growth continues. Besides, the company noted that it expects constant net revenue growth in 2019. However, forward EBITDA is not enough to justify the company's EV/ Forward EBITDA of 10x. Additionally, it is overvalued as compared to peers. A close competitor recently executed an IPO and sold shares at 5.7x EBITDA with less financial risk than LEVI. Buying shares of competitors and selling those of LEVI may be a profitable trading strategy.
Business: It Is Growing In Developed And Emerging Regions
Founded in